TRxADE HEALTH, Inc.

And welcome to TRACS 8 conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press the star, that one, on your telephone keypad. To remove your question, please press the star 2. Please note, this event is being recorded. Today with us, we have Shudang Ajarupu, Howard Doss, and Janet Huffman. I would now like to turn the conference over to the speakers. Please go ahead.

Thank you, Operator, and thank you for joining us today. I'd like to welcome you to our 2022 third quarter financial results conference call. Our press release announcing our 2022 third quarter financial results was issued after the close of market today and is posted on our website. We've also furnished such press release to the SEC on Form 8K. Statements made on this call and webcast will include forward-looking statements. These statements include, but are not limited to, our outlook for the company, and statements that estimate or project future results of operations or the performance of the company, including the potential continued impact of COVID-19, increased interest rates and inflation on the company's business, and results of operations. These statements speak only as of the date hereof, and the company assumes no obligation except as required by law to revise any forward-looking statements that may be made in today's press release, call, or webcast. These statements do not guarantee future performance and are subject to risks, uncertainties, and assumptions. For information on risks, uncertainties, and assumptions that may cause actual results to differ materially from forward-looking statements, please refer to the press release, risk factors, and documents we file with the Securities and Exchange Commission. These documents include, but are not limited to, our most recent quarterly report on Form 10-Q and any subsequently filed periodic report or current report on Form 8-K. In addition, during today's call and webcast, we will discuss non-GAAP financial measures, which we believe are useful as supplemental measures of check-based performance. These non-GAAP measures should be considered in addition to and not as a substitute for or in isolation from GAAP results. You can find additional disclosures regarding these non-GAAP measures, including reconciliations with comparable GAAP results at the end of our earnings press release. Unless otherwise stated, all financial comparisons in this call will be to our results for the comparable period of fiscal 2021. During the question-answer portion of today's call, please limit yourself to no more than one question and one follow-up. At this time, I'd like to turn the call over to Suren Ajarapu, the company's Chief Executive Officer.

Suren, the floor is yours.